(ETC)Bondex 3mg/3ml PFS - Ibandronate
- Active ingredient
Ibandronate sodium monohydrate 3.375 mg/3 mL (as Ibandronate 3 mg)
Treatment of Postmenopausal Osteoporosis
- Dosage & Administration
3 mg every 3 months administered intravenously over a period of 15 to 30 seconds.
Instruct patients to take supplemental calcium and vitamin D.
If the dose is missed, administer as soon as it can be re-scheduled. Thereafter, BONDEX Injection should be scheduled every 3 months from the date of the last injection.